Tatva Chintan Pharma Chem Limited logo

TATVA

NSE
Tatva Chintan Pharma Chem Limited (SMALL CAP)
Commodities>Chemicals>Chemicals & Petrochemicals>Specialty Chemicals
1,208.40
55.30 (4.80%)
High VOLATILITY
As on 12 Jun 2026

Price History

Market Cap
₹2.83K Cr
SMALL CAP
P/E Ratio
64.1
Industry
Specialty Chemicals
52-Week Range
52W Low886+36.4%
52W High1,610-24.9%
Current Price
1,208.40
Circuit Limits (20%)
Lower Circuit966.72
Upper Circuit1,450.08
Reference Price
1,208.40

Investment Checklist

Inverse Head and Shoulders on 1D (BREAKOUT CONFIRMED) — target ₹1321.6
Double Bottom on 1D (BREAKOUT CONFIRMED) — target ₹1321.6
Volume divergence: Bearish (price up, volume down)
EMA(9) Crossover: Price crossed above EMA(9): Fresh bullish momentum signal.
EMA(20) Crossover: Price crossed above EMA(20): Fresh bullish momentum signal.

Technical Analysis

Technical Analysis

Analysis from 2026-06-12

Confidence
50%

Trend

NEUTRAL
NEUTRAL

Mixed MA signals — sideways/transition

EMA20
1193.73
EMA50
1215.01
EMA200
1197.13

Price Action

MIXED
NEUTRAL
Higher Highs4
Higher Lows5
Lower Highs5
Lower Lows4

Support & Resistance Levels

Resistance (Above)
1246.71
1293.30
1323.00
1360.50
1393.90
Support (Below)
1208.00
1149.00
1130.00
1107.10
1085.90

Volume Analysis

TrendDECREASING
Change-32.90%
Unusual VolumeNo
Divergence Detected
Bearish (price up, volume down)

Stop Loss Levels

Fixed Risk

1% Risk1196.32
3% Risk1172.15
5% Risk1147.98
7% Risk (Custom)
1123.81

Technical Levels

1x ATR (Volatility)1154.56
2x ATR (Swing)1100.72
3x ATR (Trend)1046.88
Immediate Support1208.00

Moving Averages

EMA 9 (Short-term)1172.81
EMA 20 (Medium-term)1193.73
EMA 200 (Long-term)1197.13

Financials

Financial Analysis

MetricMar '25Jun '25Sep '25Dec '25
Revenue₹105.1 Cr₹116.9 Cr₹123.5 Cr₹131.3 Cr
Net Profit₹1 Cr₹6.7 Cr₹9.9 Cr₹15.2 Cr
EPS₹2.84₹4.24₹6.49
Operating Profit₹9.3 Cr₹18.5 Cr₹23.2 Cr₹27.2 Cr
ROE
0.77%
ROCE
1.09%
Debt/Equity
0.05
Current Ratio
2.76
OPM
20.73%
NPM
11.55%

Peer Comparison

Specialty Chemicals

Peer Comparison

SymbolNamePriceChange
PIDILITINDPidilite Industries Limited₹1,535.50+2.45%
SRFSRF Limited₹2,743.00+3.18%
FLUOROCHEMGujarat Fluorochemicals Limited₹3,655.30-0.68%
NAVINFLUORNavin Fluorine International Limited₹7,303.00+2.04%
DEEPAKNTRDeepak Nitrite Limited₹1,669.90+3.57%
ATULAtul Limited₹6,517.50+0.32%
AARTIINDAarti Industries Limited₹440.60+2.98%
AETHERAether Industries Limited₹1,142.90+1.25%
BASFBASF India Limited₹3,356.50+3.21%
FINEORGFine Organic Industries Limited₹4,724.70+1.02%

Corporate Information

Large Deals

View All

Bulk, Block and Short deals reported for this stock.

Loading Deals...

Corporate Actions

Recent actions

View All
Ex DatePurposeType
12 Sept 2025
Dividend - Re 1 Per Share
DIVIDEND
06 Sept 2024
Dividend - Rs 2 Per Share
DIVIDEND
06 Sept 2024
Annual General Meeting
AGM
08 Sept 2023
Annual General Meeting
AGM
08 Sept 2023
Dividend - Rs 2 Per Share
DIVIDEND

Announcements

Latest updates

View All
DateDescriptionLink
12 Jun 2026
Analysts/Institutional Investor Meet/Con. Call Updates
29 May 2026
Disclosure under SEBI Takeover Regulations
26 May 2026
Disclosure under SEBI Takeover Regulations
19 May 2026
Disclosure under SEBI Takeover Regulations
19 May 2026
Analysts/Institutional Investor Meet/Con. Call Updates

Board Meetings

Upcoming and past meetings

View All
DatePurposeLinks
16 May 2026
Financial Results/Dividend
16 May 2026
Board Meeting Intimation
21 Jan 2026
Board Meeting Intimation
21 Jan 2026
Financial Results
31 Oct 2025
Board Meeting Intimation

Corporate Events

Upcoming results & meetings

View All

No upcoming events found

We couldn't find any scheduled corporate actions for this symbol at the moment.

Shareholding Pattern

Shareholding Pattern

As of Dec 2025

Current Distribution

Trend (Last 8 Qtrs)

Latest News

News for TATVA

View All
NEWS
negative
Business Standard - Markets 22d ago

Link Pharma Chem reports standalone net loss of Rs 0.41 crore in the March 2026 quarter

Sales rise 2.17% to Rs 6.59 crore

DLINKINDIATATVAChemicalsInformation Technology
NEWS
positive
Business Standard - Markets 28d ago

Tatva Chintan Pharma Chem standalone net profit rises 720.00% in the March 2026 quarter

Sales rise 23.24% to Rs 132.67 crore

TATVAChemicals

Frequently Asked Questions